Tag: Investments

OJSC Pharmstandard-Leksredstva Plans to Draw $7m for Modernization in 2019

UfaVita Factory
OJSC Pharmstandard-Leksredstva, Pharmstandard’s structure based in Kursk, plans to draw 500 million rubles in 2019 for modernization. The company plans to start manufacturing 15 new pharmaceutical ...

Allergan to Invest €65M in Ireland

Pharmaceutical giants Allergan have announced the creation of 63 new jobs as part of a €65 million investment in the west of Ireland. Global life-science company, Allergan, headquartered in Ireland...

Consortium of Investors to Support the Creation of Leading Russian Pharmaceutical Holding

A consortium of investors including the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), the Russia-China Investment Fund (RCIF, established by RDIF and China Investment Corporat...

Fujifilm Invests $90m to Expand its FDB

Fujifilm Corporation announced plans to invest approximately $90 million to expand its bio contract development and manufacturing organization (CDMO) business— Fujifilm Diosynth Biotechnologies (FDB)....

PCI to Invest $20m in Biotech Technologies Development

Demand for Biotech packaging drives significant PCI investment at multiple locations world wide. PCI is pleased to announce a momentous investment in support of biologic medicines and advanced inje...

Catalent to Expand Biologics Capabilities

Catalent, a provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has started a $200m capital investment to expand biologics capacity ...

AGC boosts its biopharmaceutical production capacity

AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, has announced a major expansion of AGC Biologics, a CDMO subsidiary of the company. At AGC Biologics’ Seattle (USA) si...

Vedanta Raised $27m to Investigate Microbiome-Derived Therapies

US-based Vedanta Biosciences has raised $27 million in a Series C financing to investigate microbiome-derived therapies for several indications, including cancer and food allergy. Investors include...

Fuji Pharma makes $50 million investment in Alvotech

Alvotech (Iceland), a biopharmaceutical company announced that Fuji Pharma (Japan) has acquired a 4.2% stake in the business for approximately $50 million.

Dutch biotech signs drug development agreement with Novo Nordisk

Staten Biotechnology and Novo Nordisk have entered into a collaboration and exclusive option agreement to develop novel therapeutics for the treatment of hypertriglyceridaemia.

SGS to increase bioanalytical Capabilities by 2020

The €3.5 million investment in equipment, facilities and expert staff will significantly increase the capabilities at the site to match increasing demand and shorten processes for pharmaceutical clien...

Novo Nordisk to invest $22 million in its US facility

Novo Nordisk
Novo Nordisk(Denmark), the world’s leading diabetes care company, will invest $22 million at its Clayton facility in Johnston County (North Carolina, USA). The move comes just ten months after Novo...

UK government announced its new Life Sciences Sector Deal

The Life Sciences Sector Deal announced by the British government will support healthcare innovation and back businesses to create high-paid, high-quality jobs as part of UK's industrial strategy.

FUJIFILM Diosynth Biotechnologies receives investment for its bioscience campus

A £7 million (approximately €7,9 million) investment into FUJIFILM Diosynth Biotechnologies facility has been agreed by the local authorities of Tees Valley (UK).

Ireland aims to become an important genomics R&D hub

The Ireland Strategic Investment Fund, WuXi NextCODE and Irish life sciences company 'Genomics Medicine Ireland' announced details of a €350 million investment programme.

The European Investment Bank provides €24 million funding to F2G Biotech

The European Investment Bank is lending €24 million to Austrian F2G Biotech, a research company, focusing on the discovery and development of novel drugs to treat life threatening fungal diseases.